Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
Aduragbemi A. Faniyi, Sebastian T. Lugg, Sian E. Faustini, Craig Webster, Joanne E. Duffy, Martin Hewison, Adrian Shields, Peter Nightingale, Alex G. Richter, David R. Thickett
Source: Eur Respir J, 57 (5) 2100653; 10.1183/13993003.00653-2021
Abstract
We thank M.M. Speeckaert and co-workers for their interest in our paper about vitamin D status and seroconversion for coronavirus disease 2019 (COVID-19) in UK healthcare workers [1]. We agree with the authors that vitamin D binding protein (DBP) is important in determining serum 25(OH)D3 levels. The majority of vitamin D in the circulation is bound to DBP, also known as gc-globulin, which has actin-binding and immunomodulatory functions independent of vitamin D carriage [2]. DBP levels may be particularly relevant to determining 25(OH)D3 levels in severely ill COVID-19 patients with acute respiratory distress syndrome (ARDS), as we have previously demonstrated that DBP is a negative acute phase protein with levels dropping by about a third in patients with ARDS [3]. This tends to lower circulating total vitamin D but releases free 25(OH)D that can be taken up by cells of the immune system and epithelial cells. The consequences of changes in serum 25(OH)D during illness are, therefore, complex and difficult to interpret [4]. Genome-wide association analyses have shown that single nucleotide polymorphisms (SNPs) in the gene for DBP (GC ) are important contributors to the genetic component of circulating 25D concentrations, but this is still a relatively small proportion of overall serum 25D levels, and it is unclear how these SNPs impact DBP/25D homeostasis in the setting of disease.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Aduragbemi A. Faniyi, Sebastian T. Lugg, Sian E. Faustini, Craig Webster, Joanne E. Duffy, Martin Hewison, Adrian Shields, Peter Nightingale, Alex G. Richter, David R. Thickett. Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19. Eur Respir J, 57 (5) 2100653; 10.1183/13993003.00653-2021
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Association of vitamin D deficiency with COPD and vitamin D binding proteins Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009
Vitamin D receptor and vitamin D binding protein polymorphisms are associated with asthma control in children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status Source: Eur Respir J 2010; 35: 1106-1112 Year: 2010
The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015
Vitamin D receptor gene Fok 1 polymorphism and bone metabolism in children with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 163s Year: 2005
Vitamin D binding protein (DBP) levels during tuberculosis treatment are affected by DBP genotype / haplotype but not by total vitamin D levels Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Diet related vitamin D deficiency and reactivation of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 416s Year: 2004
The effect of 1,25-(OH)2 D3 supplementation on the expression of vitamin D receptor (VDR) on the lung of baby rats with asthma Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012
The role of vitamin D receptor BsmI polymorphism in the course of sarcoidosis Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
Vitamin D deficiency and FEV1 decline in COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Association of vitamin D receptor (Fok-I) polymorphism with asthma in Tunisian children Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011
Vitamin D deficiency is very common in London tuberculosis contacts Source: Eur Respir J 2004; 24: Suppl. 48, 34s Year: 2004
Clinical impact of vitamin D deficiency on Tunisian asthmatics Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Vitamin D receptor polymorphisms and exacerbation frequency in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Polymorphisms of the vitamin D receptor(VDR ) gene, collagen type I alpha 1(COLIA1 ) gene in Polish sarcoidosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 114s Year: 2007
Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status Source: Annual Congress 2010 - Tuberculosis: from bench to bedside Year: 2010
The role of vitamin D3 in sarcoidosis (SA) Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010
The relationship between vitamin D deficiency and the main characteristics of COPD patients Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Vitamin D binding protein variants associate asthma susceptibility in a Chinese Han population Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011